BIOWAIVER
=
WAIVER (EXEMPTION)
OF IN VIVO BIOAVAILABILITY & BIO EQUIVALENCE STUDIES
|
The term biowaiver is applied to a regulatory drug approval
process when the dossier (application) is approved based on evidence of equivalence
other than in vivo
bioequivalence studies.
No comments:
Post a Comment